Once-monthly efimosfermin alfa prescribed for metabolic dysfunction–associated steatohepatitis with F2 and F3 fibrosis ...

Use of the investigational drug efruxifermin did not significantly reduce fibrosis in patients with compensated cirrhosis ...

AMSTERDAM — A once daily, 50 mg dose of efruxifermin reduced fibrosis at 96 weeks in patients with compensated cirrhosis due to metabolic dysfunction-associated steatohepatitis (MASH) compared with ...

Naim Alkhouri, MD, spoke to the potential for glucagon-like peptide-1 (GLP-1) receptor agonists to transform the treatment landscape for patients with metabolic dysfunction-associated steatohepatitis ...

Target RWE, a leader in modern clinical evidence generation for complex diseases, today announced its presentations and strategic contributions at the EASL Congress 2025 in Amsterdam, Netherlands.

Making crispy fries at home can be quite an effort. Meanwhile, delicious potato balls always turn out soft on the inside and ...

Though there are very few characters in MASH who aren't beloved by audiences and critics, these individuals rise to the top ...

This local sensation mashes up pop and rock hits with a full brass section, turning every show into a high-energy singalong.

Beyoncé took the SoFi stage for night four of her "Cowboy Carter" tour. For the third night in a row, she added some ...

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...

Here are five bourbons, top picks at the SFWSC, that you must try. All five bourbons are finalists for the coveted prize of ...

The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...